🔗 Share this article

Following a postponement and a particularly heated session, a government vaccine expert group was scheduled to decide on Friday regarding a potential change to the longstanding recommendation that every infant be vaccinated against hepatitis B.

Intense Discussion and a Deferred Vote

The opening session of the conference on Thursday was marked by fiery discussion over limiting availability to the hepatitis B vaccine for babies and a decision to postpone the decision by a day to allow panelists additional time to scrutinize the phrasing. The panel, which guides the national health agency on immunization practices, had put off the vote twice in the past.

“Is there any specific evidence of injury of giving this shot before 30 days? Or is this conjecture?” asked one committee member.

In response, another member stated, “There is inadequate data about the enduring danger.”

Existing Recommendations and Likely Ramifications

The shot is currently suggested for every newborn within 24 hours of delivery to halt contraction of hepatitis B, which can cause major damage to the liver. It has been administered to more than a billion persons for in excess of thirty years.

The meeting in Atlanta offered no new evidence of harms caused by the vaccine. Experts say any modification to the present hepatitis B immunization timeline could have profound and widespread consequences for infant and child health in the United States.

Group Membership and Latest Shifts

The expert committee can only offer guidance to the leader of the CDC. The committee's composition has undergone changes this week, with the declaration that the panel's latest chairman would leave for an agency job and be succeeded by a cardiac doctor who has been skeptical about other vaccines.

The committee includes a number of immunization doubters who support a aim to revamp – and perhaps, in some cases, abolish – traditional vaccination recommendations.